A total of 1.4 million people will die of cancer in 2019 in the European Union (EU), according to research published today in the British oncology journal "Annals of Oncology" and conducted by the Italian Carlo La Vecchia, professor of the Faculty of Medicine of the University of Milan (north).
This figure will represent an increase of 4.8% compared to the 1.35 million deaths in 2014, highlights the report by La Vecchia and a team of experts of the European Society of Medical Oncology, based in Switzerland.
By sex, 787,000 of the victims will be men and 621,900 women.
And by types of cancer, researchers indicate that the lung cancer will continue to be the leading cause of death in both sexes, given that it is expected that 183,200 men and 96,800 women will die from this disease.
This is the ninth consecutive year in which these researchers publish their predictions and this year predict in the specific case of breast cancer that mortality rates will be reduced by almost 9% in the EU as a whole compared to 2014, but will increase in Poland by just over 2%.
Of the six largest countries, the United Kingdom has the largest projected decrease in deaths from breast cancer by 2019 (13%), followed by France (10%), Germany (9%), Italy (7%) or Spain ( 5%), while in Poland there is an expected increase of 2%.
The study shows that breast cancer remains the second cause of cancer death in women after lung cancer.
"In 2014 there were 92,000 deaths from breast cancer in Europe and in 2019 we believe there will be 92,800 (...) This means that the burden of the disease will continue to rise, with consequent implications for public health and costs for society" said Professor La Vecchia.
According to the document, improvements in breast cancer mortality rates are due to national screening programs, early diagnosis and improvements in the management and treatment of the disease.
Compared to the period between 2010 and 2014, these experts predict that mortality rates standardized by age for breast cancer will decrease by 16% in 2019 in women between 50 and 69 years, and only 6% in women aged between between 70 and 79 years old.
In Poland and other Eastern European countries, experts do not see favorable predictable patterns in deaths from breast cancer, so they suggest the need to improve the diagnosis and treatment of breast cancer.
The professor emeritus of the Faculty of Biology and Medicine of the University of Lausanne (Switzerland) Fabio Levi justifies that "the tendencies of lung cancer have been decreasing in European men", but he warns that "they are less favorable than those of United".
"More than 20% of European adults still smoke, compared to less than 15% in the US This situation requires urgent interventions on tobacco for men and women in the EU," he concludes.